|
 |
|
EDITORIAL COMMENTARY |
|
|
|
| Year : 2022 | Volume
: 25
| Issue : 2 | Page : 187-188 |
| |
Scrub typhus for the neurologist: Forget me not
Tamilarasu Kadhiravan
Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
| Date of Submission | 25-Nov-2021 |
| Date of Acceptance | 04-Mar-2022 |
| Date of Web Publication | 10-Mar-2022 |
Correspondence Address:
Tamilarasu Kadhiravan
Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Puducherry - 605 006
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aian.aian_1011_21
How to cite this article:
Kadhiravan T. Scrub typhus for the neurologist: Forget me not. Ann Indian Acad Neurol 2022;25:187-8 |
Scrub typhus is an important yet underrecognized cause of acute febrile illness in India. In a multicentric study done at seven community hospitals located in six different states, 10% of patients with undifferentiated acute febrile illness had serological evidence of scrub typhus.[1] Given that this illness derives its name from the Greek word typhos, which means smoke or fog, alluding to the clouding of sensorium,[2] it is not surprising that scrub typhus commonly affects the central nervous system. In fact, outbreaks of acute encephalitis syndrome among children in some geographical regions are epidemiologically linked with serological evidence of Orientia tsutsugamushi infection.[3] What is rather interesting is the frequent occurrence of neurological manifestations such as opsoclonus-myoclonus, cranial nerve palsies including neural deafness, and status epilepticus as a manifestation of scrub typhus.
Notwithstanding its clinical relevance and importance, comprehensive reviews on neurological manifestations of scrub typhus are very few.[4],[5] A recent issue of the Journal carried an important article on the neurological manifestations of scrub typhus.[6] The authors, Garg and Manesh, presented a succinct, up-to-date description of various neurological manifestations among adults with scrub typhus. Although their review was primarily narrative, inclusion of studies and reports into this narrative synthesis was informed by a fairly systematic search of literature published in English. Notably, the authors presented a conceptual timeline of various neurological manifestations and also provided valuable insights into the possible pathogenetic mechanisms responsible for these manifestations.
A few points from this review are worth highlighting. First, cerebrospinal fluid (CSF) glucose levels are typically normal or only slightly decreased in scrub typhus meningitis, as opposed to tuberculous meningitis which is characterized by low CSF glucose levels. Overlooking this important clue, clinicians often initiate tuberculosis treatment and feel vindicated by the clinical response brought about by rifampicin, which is also effective against scrub typhus. As rightly pointed out by the authors, presence of thrombocytopenia, elevated liver enzymes, and acute kidney injury should alert the clinician to the possibility of scrub typhus when there is lymphocytic pleocytosis with normal CSF glucose level.
Second, many of the neurological manifestations improve without adjunctive immunosuppressive treatment. Rickettsial meningoencephalitis is characterized by the presence of typhus nodules—focal perivascular mononuclear cell infiltrates—in the brain parenchyma and meninges.[7] Similar pathological changes have been noted to involve the VIII nerve and inner ear in British soldiers who succumbed to epidemic typhus in South East Asia during the World War II.[8] All of them had hearing loss as an early manifestation of typhus. O. tustsugamushi directly infects endothelial cells of various organs including the brain.[9] Typhus nodules probably represent sites of active rickettsial multiplication, and this may explain why many of the neurological manifestations of scrub typhus improve with antibacterial treatment alone.
Third, prognosis of patients with multiorgan dysfunction associated with scrub typhus is distinctly better compared to other bacterial infections, if treated appropriately.[10] Given that scrub typhus is fairly common and that the sensitivity of point-of-care tests is suboptimal,[11] should professional society guidelines include doxycycline in their empiric treatment recommendations for acute meningitis and meningoencephalitis in endemic regions? Indeed, many clinicians would presumptively add doxycycline while treating patients with acute meningoencephalitis in such settings.[12] I believe, they are correct in doing so. While doxycycline and azithromycin are equally effective,[13] the optimal treatment strategy in those with severe scrub typhus is yet unknown. Particularly, it is unclear at present whether a combination of doxycycline and azithromycin would be superior to monotherapy in patients with severe disease. Ongoing clinical trials are expected to clarify this issue.[14],[15]
Finally, it is worthwhile to ask the question “Does scrub typhus have long-term health consequences?” Many rickettsial pathogens, including O. tsutsugamushi, are known to persist in animals for prolonged periods of time.[16] Viable O. tsutsugamushi has been isolated on several occasions from asymptomatic humans several months after recovering from scrub typhus.[17],[18] It has been suggested that such latent infection could have health consequences.[18] At least two population-based cohort studies indicate an increased risk of acute coronary syndromes among adults who had recovered from scrub typhus.[19],[20] Although no excess of strokes was observed in one of these studies,[19] there is no reason why there should be a discordant association. Long-term health consequence of scrub typhus remains an understudied area.[21] No doubt, more research is needed to explore this interesting aspect of scrub typhus, and this could be of particular interest to neurologists.
 References | |  |
| 1. | Mørch K, Manoharan A, Chandy S, Chacko N, Alvarez-Uria G, Patil S, et al. Acute undifferentiated fever in India: A multicentre study of aetiology and diagnostic accuracy. BMC Infect Dis 2017;17:665.  |
| 2. | Stedman TL. Stedman's Medical Dictionary. 26 th ed. Baltimore: Williams & Wilkins; 1995. |
| 3. | Mittal M, Thangaraj JWV, Rose W, Verghese VP, Kumar CPG, Mittal M, et al. Scrub typhus as a cause of acute encephalitis syndrome, Gorakhpur, Uttar Pradesh, India. Emerg Infect Dis 2017;23:1414-6. |
| 4. | Mahajan SK, Mahajan SK. Neuropsychiatric manifestations of scrub typhus. J Neurosci Rural Pract 2017;8:421-6. [ PUBMED] [Full text] |
| 5. | Sekeyová Z, Danchenko M, Filipčík P, Fournier PE. Rickettsial infections of the central nervous system. PLoS Negl Trop Dis 2019;13:e0007469. doi: 10.1371/journal.pntd. 0007469. |
| 6. | Garg D, Manesh A. Neurological facets of scrub typhus: A comprehensive narrative review. Ann Indian Acad Neurol 2021;24:849-64. [Full text] |
| 7. | Levine HD. Pathologic study of thirty-one cases of scrub typhus fever with especial reference to the cardiovascular system. Am Heart J 1946;31:314-28. |
| 8. | Friedmann I, Frohlich A, Wright A. Epidemic typhus fever and hearing loss: A histological study (Hallpike collection of temporal bone sections). J Laryngol Otol 1993;107:275-83. |
| 9. | Moron CG, Popov VL, Feng HM, Wear D, Walker DH. Identification of the target cells of orientia tsutsugamushi in human cases of scrub typhus. Mod Pathol 2001;14:752-9. |
| 10. | Varghese GM, Trowbridge P, Janardhanan J, Thomas K, Peter JV, Mathews P, et al. Clinical profile and improving mortality trend of scrub typhus in South India. Int J Infect Dis 2014;23:39-43. |
| 11. | Saraswati K, Day NPJ, Mukaka M, Blacksell SD. Scrub typhus point-of-care testing: A systematic review and meta-analysis. PLoS Negl Trop Dis 2018;12:e0006330. doi: 10.1371/journal.pntd. 0006330. |
| 12. | The Indian Society of Critical Care Medicine Tropical fever Group, Singhi S, Chaudhary D, Varghese GM, Bhalla A, Karthi N, et al. Tropical fevers: Management guidelines. Indian J Crit Care Med 2014;18:62-9. |
| 13. | El Sayed I, Liu Q, Wee I, Hine P. Antibiotics for treating scrub typhus. Cochrane Database Syst Rev 2018;9:CD002150. |
| 14. | |
| 15. | Clinical Trials Registry India [Internet]. New Delhi: ICMR-National Institute of Medical Statistics (India); 2007. Identifier CTRI/2020/10/028236, Comparing efficacy of azithromycin, doxycycline, and combination therapy in treatment of complicated scrub typhus: A triple blinded randomized controlled trial; 2020 Oct 05. p. 1. Available from: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47833. [Last accessed on 2021 Nov 24]. |
| 16. | Fox JP. The long persistence of rickettsia orientalis in the blood and tissues of infected animals. J Immunol 1948;59:109-14. |
| 17. | Smadel JE, Ley HL Jr, Diercks RH, Cameron JA. Persistence of rickettsia tsutsugamushi in tissues of patients recovered from scrub typhus. Am J Hyg 1952;56:294-302. |
| 18. | Chung MH, Lee JS, Baek JH, Kim M, Kang JS. Persistence of orientia tsutsugamushi in humans. J Korean Med Sci 2012;27:231-5. |
| 19. | Jung LY, Lee J, Jeon M, Hwang JH, Hong JY, Lee CS. Risk of cerebro- and cardiovascular disease in patients with scrub typhus. Eur J Clin Microbiol Infect Dis 2020;39:451-4. |
| 20. | Chung WS, Lin CL, Hsu WH, Kao CH. Scrub typhus increases the risk of developing acute coronary syndrome: A nationwide cohort study. Heart 2014;100:1844-50. |
| 21. | Paris DH, Shelite TR, Day NP, Walker DH. Unresolved problems related to scrub typhus: A seriously neglected life-threatening disease. Am J Trop Med Hyg 2013;89:301-7. |
|
|
|
|
|
|
|
|
